# HD12 for Advanced Stages

> **NCT00265031** · PHASE3 · COMPLETED · sponsor: **University of Cologne**

## Conditions studied

- Hodgkin´s Lymphoma

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Adriamycin
- **DRUG:** Etoposide
- **DRUG:** Procarbazine
- **DRUG:** Prednisone
- **DRUG:** Vincristine
- **DRUG:** Bleomycin
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00265031
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265031, "HD12 for Advanced Stages". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00265031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*